egnite, a digital health company specialising in cardiovascular care, has announced the addition of Vinod Thourani (Piedmont Heart Institute, Atlanta, USA) and Nicholas Amoroso (Medical University of South Carolina, Charleston, USA) to its medical advisory board.
Their expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide, the company said in a press release.
Thourani is the Bernie Marcus chairman of the Department of Cardiovascular Surgery for Piedmont Heart Institute and Piedmont Healthcare and the Marcus Heart Valve Center, strengthening egnite’s medical advisory board with his background in cardiovascular surgery and academic research. Over Thourani’s distinguished career, he has held key leadership positions as the past-president of the Southern Thoracic Surgical Association, past-president of the Heart Valve Society, past-president of the International Society of Minimally Invasive Cardiothoracic Surgery, president-elect of the 21st Century Cardiothoracic Surgical Society, past-president of the South Atlantic Cardiovascular Surgery, and the Treasurer of the Society of Thoracic Surgeons. He has authored over 740 peer-reviewed publications in major medical journals. Thourani’s leadership roles in prominent cardiovascular associations and research underscore his invaluable contributions to furthering egnite’s mission and the direction of its flagship solution, the CardioCare platform, the company says.
Amoroso is an interventional cardiologist and director of the Medical University of South Carolina’s Adult Cardiac Catheterization Laboratory who brings expertise in structural heart and coronary artery disease to the advisory board. Amoroso is an emerging leader in the field, serving as an investigator for several landmark structural heart clinical trials and as a proctor for novel structural heart interventions. Amoroso’s prominent background in cardiology includes medical training at George Washington University as well as residency and fellowship programs at NYU and Mount Sinai Beth Israel, egnite says. His involvement in novel clinical trials and contributions to leading cardiology research brings a wealth of experience to egnite’s medical advisory board.
“We are honoured to welcome Vinod and Nick to egnite’s medical advisory board,” said Joel Portice, president and CEO of egnite. “Their collective expertise will play a pivotal role in shaping the future of digital health for cardiovascular patients. I look forward to Vinod and Nick’s partnership as we continue to develop innovative solutions in the cardiovascular community.”
